The bill mandates that public postsecondary institutions in Minnesota maintain a supply of opiate antagonists, specifically requiring at least two doses of nasal naloxone to be available on each campus building. The Board of Trustees of the Minnesota State Colleges and Universities is tasked with this responsibility, while the Board of Regents of the University of Minnesota is requested to comply. Additionally, the commissioner of health is directed to provide resources, including training materials, to assist institutions in implementing an emergency response plan for opiate overdoses. This requirement will take effect in the 2024-2025 academic year.

Furthermore, the bill amends Minnesota Statutes 2023 Supplement, section 151.37, subdivision 12, to include personnel from postsecondary institutions among those authorized to administer opiate antagonists during drug overdoses. This inclusion expands the list of individuals who can administer these life-saving medications, provided they have received appropriate training and a standing order from a licensed medical professional. The bill aims to enhance the preparedness of educational institutions in responding to opiate overdoses, thereby promoting student safety and health on campuses.